ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in Washington, DC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Lung Cancer

Breast Cancer trials near Washington, DC, USA:

Niraparib + Dostarlimab In BRCA Mutated Breast Cancer

This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...

Enrolling
Breast Cancer
Stage II Breast Cancer
Drug: Niraparib
Drug: Dostarlimab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Baltimore, Maryland, United States and 8 other locations

would like to study the genetic and molecular outcomes that results after a short term neoadjuvant hormonal therapy on patients with breast ....

Active, not recruiting
Breast Cancer
Drug: Tamoxifen Citrate
Drug: Exemestane

Phase 2

Johns Hopkins University
Johns Hopkins University

Baltimore, Maryland, United States

radiation treatment after undergoing a lumpectomy, also known as "breast conserving surgery". In this trial, we are attempting to identify w...

Active, not recruiting
Breast Cancer Radiation
Device: Prosigna

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Baltimore, Maryland, United States and 5 other locations

This research study is for patients with metastatic breast cancer.Metastatic means that the cancer has spread beyond the b...

Active, not recruiting
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
Drug: Olaparib

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Baltimore, Maryland, United States and 19 other locations

This is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the safety and ...

Active, not recruiting
Breast Cancer
Drug: Avelumab
Drug: Talazoparib

Phase 1, Phase 2

Georgetown University
Georgetown University

Washington, District of Columbia, United States and 1 other location

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Retifanlimab

Phase 3

BriaCell Therapeutics

Fredericksburg, Virginia, United States and 3 other locations

triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...

Enrolling
Hormone Receptor Positive (HR+), HER2-negative Breast Cancer
Triple Negative Breast Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 2

Laura M. Spring, MD

Washington, District of Columbia, United States and 9 other locations

This study is being done to look at the role of continuing palbociclib treatment in combination with another type of hormonal therapy (fulvestrant) a...

Active, not recruiting
Metastatic Breast Cancer
Drug: Palbociclib
Drug: Fulvestrant

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Washington, District of Columbia, United States and 4 other locations

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Washington, District of Columbia, United States and 9 other locations

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

Washington, District of Columbia, United States and 8 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems